1467-84-1 Usage
Description
Trans-4-Aminocyclohexanemethanol is an organic compound with the molecular formula C7H15NO. It is a white solid and is a metabolite of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (Me CCNU). trans-4-Aminocyclohexanemethanol has a cyclohexane ring with an amino group and a methanol group attached, which may contribute to its potential applications in various industries.
Uses
Used in Pharmaceutical Industry:
Trans-4-Aminocyclohexanemethanol is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a key component in the development of new drugs, particularly those targeting the central nervous system or other biological processes that can benefit from its specific chemical properties.
Used in Chemical Research:
As a white solid with distinct chemical properties, trans-4-Aminocyclohexanemethanol can be used in chemical research to study the effects of its structure on various reactions and interactions with other molecules. This can lead to a better understanding of its potential applications and the development of new compounds with similar structures.
Used in Material Science:
The unique structure of trans-4-Aminocyclohexanemethanol may also find applications in material science, where it could be used to develop new materials with specific properties. For example, its cyclohexane ring and amino group could be exploited to create materials with enhanced mechanical, electrical, or thermal properties.
Check Digit Verification of cas no
The CAS Registry Mumber 1467-84-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,6 and 7 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1467-84:
(6*1)+(5*4)+(4*6)+(3*7)+(2*8)+(1*4)=91
91 % 10 = 1
So 1467-84-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H15NO/c8-7-3-1-6(5-9)2-4-7/h6-7,9H,1-5,8H2/t6-,7-
1467-84-1Relevant articles and documents
IRAK DEGRADERS AND USES THEREOF
-
Paragraph 00920; 001309-001310, (2021/01/23)
The present invention provides compounds, compositions thereof, and methods of using the same. The compounds include an IRAK binding moiety capable of binding to IRAK4 and a degradation inducing moiety (DIM). The DIM could be DTM a ligase binding moiety (LBM) or lysine mimetic. The compounds could be useful as IRAK protein kinase inhibitors and applied to IRAK mediated disorders.
NEW BICYCLIC DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
-
, (2016/04/20)
The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY
-
Page/Page column 136, (2014/07/08)
The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
